Ultime notizie per Coya Therapeutics (NASDAQ:COYA) Azioni

Coya Therapeutics

Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.

Coya Therapeutics Inc

Stride Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LRN#NYSE">LRN</a>) shares are rising in extended trading on Tuesday after the company reported better-than-expected financial results for the third quarter and raised its full-year outlook. Here&#8217;s a look at the key metrics <a href="https://www.benzinga.com/pressreleases/25/04/g45083361/strong-demand-delivers-another-record-quarter-for-stride">from the quarter</a>.
<ul>
<li>Q3 Revenue: $613.38 million, versus <a href="https://www.benzinga.com/calendars/earnings">estimates</a> of $591.07 million</li>
</ul>
<ul>
<li>Q3 EPS: $2.02, versus estimates of $2</li>
</ul>
Third-quarter enrollments averaged 240,200, up 21% on a year-over-year basis. Of the total average enrollments, 98,700 were Career Learning enrollments, up&nbsp;33.7% year-over-year. Revenue per enrollment came in at $2,415 in the quarter, down slightly compared to $2,420 in the prior year&#8217;s quarter.
Stride said it ended the period with $754.6 million in cash, cash equivalents and marketable securities. 
Outlook: Stride raised full-year revenue guidance from a range of $2.32 billion to $2.35 billion to a new range of $2.37 billion to $2.38 billion versus estimates of $2.34 billion, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Stride offers innovative education solutions, serving learners in primary, secondary and postsecondary settings.
LRN Price Action: <a href="http://benzinga.com/quote/lrn">Stride shares</a> were up 3.71% after the bell, trading at $147.88 at the time of publication on Tuesday. According to <a href="http://pro.benzinga.com">Benzinga Pro</a>, Stride shares are up approximately 37% year-to-date, and a whopping 113% over a one-year period.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/04/45086254/super-micro-computer-stock-is-tanking-after-hours-whats-fueling-the-sell-off">Super Micro Computer Stock Is Tanking After Hours: What&#8217;s Fueling The Sell-Off?</a></li>
</ul>
Photo: T. Schneider/Shutterstock.

Earnings

News

Guidance

Movers

Stride Stock Surges To All-Time High Following Better-Than-Expected Q3 Results

Nexa Res (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NEXA#NYSE">NEXA</a>) reported quarterly earnings of $0.16 per share which beat the analyst consensus estimate of $0.06 by 166.67 percent. This is a 200 percent increase over losses of $(0.16) per share from the same period last year. The company reported quarterly sales of $627.00 million which missed the analyst consensus estimate of $628.65 million by 0.26 percent. This is a 8.10 percent increase over sales of $580.00 million the same period last year.

Earnings Beats

Earnings Misses

NEXA

Nexa Res Q1 Adj. EPS $0.16 Beats $0.06 Estimate, Sales $627.00M Miss $628.65M Estimate

Jefferies analyst Jonathan Matuszewski maintains Beyond (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BYON#NYSE">BYON</a>) with a Hold and lowers the price target from $6.5 to $5.

Price Target

Analyst Ratings

BYON

Jefferies Maintains Hold on Beyond, Lowers Price Target to $5

Guggenheim analyst Gregory Francfort reiterated the Neutral rating on Starbucks Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) on Tuesday, <a href="https://www.benzinga.com/quote/SBUX/analyst-ratings" target="_blank" rel="noreferrer noopener">lowering the price forecast from $95 to $83.</a>
Starbucks reported second-quarter fiscal year 2025 financial results after <a href="https://www.benzinga.com/news/earnings/25/04/45084597/starbucks-misses-q2-earnings-estimates-ceo-says-optimism-has-turned-into-confidence-i-see-more-opportunity-than-i-imagined">market close on Tuesday.</a>
Starbucks reported Q2 revenue of $8.76 billion, missing the $8.86 billion analyst estimate, and adjusted EPS of $0.41, below the $0.50 consensus. 
Consolidated net revenue rose 2% year-over-year, but global comparable store sales fell 1% (transactions down 2%, average ticket up 1%), with North America down 1%, international down 2%, and China flat.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/04/45064674/how-to-earn-500-a-month-from-starbucks-stock-ahead-of-q2-earnings" rel="noreferrer noopener">How To Earn $500 A Month From Starbucks Stock Ahead Of Q2 Earnings</a>
In the note issued on Monday, Francfort cited rising competition from local brands like CHA, the impact of the trade war, and potential resistance to U.S. brands as factors that add to the risks for Starbucks.
Margin expansion forecasts are lowered, with 2027 EBIT margins now seen improving by ~150 basis points over 2025, down from ~270 basis points previously.
This adjustment factors in expected relief in arabica coffee prices, currently stuck above $4 per pound but forecast to dip to the low $3s by late 2026, the analyst writes.
Meanwhile, Starbucks' U.S. workforce has shrunk about 3% over five years even as store count rose 12%, suggesting continued pressure on managing store operating costs.
Francfort notes that Starbucks, being a discretionary purchase, could face added pressure if consumer conditions deteriorate further.
SBUX Price Action: <a href="https://www.benzinga.com/quote/SBUX" target="_blank" rel="noreferrer noopener">Starbucks shares</a> were down 1.24% in the after-hours session, trading at $83.80 at the time of publication Tuesday, per <a href="http://pro.benzinga.com/" target="_blank" rel="noreferrer noopener">Benzinga Pro</a> data.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/04/45078739/stocks-surge-and-bond-yields-fall-for-6th-day-oil-prices-drop-to-60-whats-driving-markets-tuesday" target="_blank" rel="noreferrer noopener">Stocks Surge And Bond Yields Fall For 6th Day, Oil Prices Drop To $60: What&#8217;s Driving Markets Tuesday?</a></li>
</ul>
Photo: Shutterstock

Equities

Markets

Trading Ideas

General

SBUX

Analyst Warns Starbucks Faces Growing Risks From Competition, Costs, and Global Tensions

Management

FAT Brands Appoints Taylor Wiederhorn As Co-CEO

Janney Montgomery Scott analyst Jake Civiello downgrades HarborOne Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HONE#NASDAQ">HONE</a>) from Buy to Neutral.

Downgrades

HONE

Janney Montgomery Scott Downgrades HarborOne Bancorp to Neutral

OUST

Ouster Names Kenneth Gianella As Chief Financial Officer, Effective May 19, 2025

DA Davidson analyst Rudy Kessinger maintains CommVault Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CVLT#NASDAQ">CVLT</a>) with a Buy and raises the price target from $185 to $200.

CVLT

DA Davidson Maintains Buy on CommVault Systems, Raises Price Target to $200

Lennox Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LII#NYSE">LII</a>) has outperformed the market over the past 5 years by 9.17% on an annualized basis producing an average annual return of 23.51%. Currently, Lennox Intl has a market capitalization of $18.98 billion. 
Buying $100 In LII: If an investor had bought $100 of LII stock 5 years ago, it would be worth $291.77 today based on a price of $534.91 for LII at the time of writing.
<h3>Lennox Intl's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745963113_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Lennox Intl 5 Years Ago Would Be Worth Today

Algoma Steel Gr (TSX:<a class="ticker" href="https://www.benzinga.com/stock/ASTL#TSX">ASTL</a>) reported quarterly losses of $(0.48) per share. This is a 585.71 percent decrease over losses of $(0.07) per share from the same period last year. The company reported $517.10 million in sales this quarter. This is a 20.51 percent decrease over sales of $650.50 million the same period last year.

TSX:ASTL

Algoma Steel Gr Q1 EPS $(0.48) Down From $(0.07) YoY, Sales $517.10M Down From $650.50M YoY

Macquarie analyst Paul Golding maintains PayPal Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>) with a Outperform and lowers the price target from $117 to $95.

PYPL

Macquarie Maintains Outperform on PayPal Holdings, Lowers Price Target to $95

Jones Trading analyst Jason Weaver maintains Franklin BSP Realty Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FBRT#NYSE">FBRT</a>) with a Buy and lowers the price target from $15 to $14.

FBRT

Jones Trading Maintains Buy on Franklin BSP Realty Trust, Lowers Price Target to $14

Flushing Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIC#NASDAQ">FFIC</a>) reported quarterly earnings of $0.23 per share which beat the analyst consensus estimate of $0.21 by 9.52 percent. This is a 64.29 percent increase over earnings of $0.14 per share from the same period last year. The company reported quarterly sales of $58.06 million which beat the analyst consensus estimate of $55.38 million by 4.84 percent. This is a 27.66 percent increase over sales of $45.48 million the same period last year.

FFIC

Flushing Financial Q1 Adj. EPS $0.23 Beats $0.21 Estimate, Sales $58.06M Beat $55.38M Estimate

Brinker International Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EAT#NYSE">EAT</a>) shares fell on Tuesday after it reported third-quarter FY25 earnings. The company owns and operates brands like Chili's Grill &amp; Bar and Maggiano's Little Italy.
The company reported <a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/n45061910/brinker-international-reports-third-quarter-of-fiscal-2025-results-and-updates-fiscal-2025-guidanc" rel="noreferrer noopener">third-quarter revenue growth of 27.2%</a> year-on-year to $1.43 billion, beating the analyst consensus estimate of $1.39 billion. Adjusted EPS of $2.66 <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">beat the analyst consensus</a> of $2.57.
Brinker's comparable restaurant sales rose 28.2%, Chili's rose 31.6%, and Maggiano's by 0.4%.
Operating margin expanded 480 basis points to 11%, and operating income more than doubled to $156.9 million for the quarter.
Also Read: <a target="_blank" href="https://www.benzinga.com/news/25/04/45039495/dominos-pizza-q1-operating-margin-shrinks-as-lower-income-consumers-feel-the-pinch" rel="noreferrer noopener">Domino's Pizza Q1 Operating Margin Shrinks As Lower-Income Consumers Feel the Pinch</a>
The restaurant operating margin for the quarter was 18.9%, compared to 14.2% last year.
As of March 26, 2025, the company held $17.5 million in cash and equivalents. Operating cash flow for the nine months totaled $493 million.
Adjusted EBITDA of $220.6 million improved by 80% Y/Y.
"Our continued progress on the fundamentals of great food, great service in a fun, friendly atmosphere is clearly winning with guests," said Kevin Hochman, President &amp; CEO.
On the earnings call, Brinker said that roughly 20% of its food and beverage purchases are imported. The tariffs on imported goods could raise input costs and hurt margins.
Outlook: Brinker raised its FY25 revenue outlook from $5.15 billion—$5.25 billion to $5.33 billion—$5.35 billion, versus the consensus of $5.25 billion.
The company raised FY25 Adjusted EPS guidance from $7.50 &#8211; $8.00 to $8.50 &#8211; $8.75, against the consensus of $8.48.
Price Action: EAT shares closed lower by 14.80% to $136.89 on Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/04/45085373/oscar-mayer-and-jell-o-maker-kraft-heinz-feels-macro-economic-pinch-cuts-profit-outlook" target="_blank" rel="noreferrer noopener">Oscar Mayer And Jell-O Maker Kraft Heinz Feels Macro Economic Pinch, Cuts Profit Outlook</a></li>
</ul>
Photo by CarlyZel via Shutterstock

Why Did Chili's Restaurant Parent Brinker International Stock Tumble On Tuesday?

Tigress Financial analyst Ivan Feinseth maintains T-Mobile US (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TMUS#NASDAQ">TMUS</a>) with a Buy and raises the price target from $290 to $305.

TMUS

Tigress Financial Maintains Buy on T-Mobile US, Raises Price Target to $305

Caesars Entertainment Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CZR#NASDAQ">CZR</a>) reported first-quarter earnings Tuesday after the bell. Here&#8217;s a rundown <a href="https://www.benzinga.com/pressreleases/25/04/b45082376/caesars-entertainment-inc-reports-first-quarter-2025-results">of the report</a>.
<ul>
<li>Q1 Revenue: $2.79 billion, versus <a href="https://www.benzinga.com/calendars/earnings">estimates</a> of $2.79 billion</li>
</ul>
<ul>
<li>Q1 EPS: Loss of 54 cents, versus estimates for a loss of 16 cents</li>
</ul>
Broken down by segment, Caesars reported approximately $1 billion in revenue from Las Vegas, $1.39 billion in Regional revenue, $335 million in Caesars Digital revenue, $67 million in Managed and Branded revenue and $1 million in Corporate and Other revenue.
The company ended the quarter with $884 million in cash and cash equivalents, and $12.3 billion in outstanding debt.
&#8220;During the&nbsp;first quarter&nbsp;of 2025, consolidated Adjusted EBITDA grew&nbsp;4%&nbsp;over prior year driven by significant gains in our Digital segment which delivered a new&nbsp;Q1&nbsp;record, growth in our regional segment with strong contributions from recently opened properties and a solid quarter in Las Vegas against a tough Super Bowl compare last year,&#8221; said Tom Reeg, CEO of Caesars Entertainment.
Caesars said it repurchased approximately $100 million worth of its common stock during April at an average price of $23.84 per share. 
The company expects to accelerate free cash flow in 2025, allowing it to continue to reduce debt and make opportunistic share repurchases. 
&#8220;We continue to expect 2025 to benefit from meaningfully lower year-over-year capital expenditures and cash interest expense. When combined with strong operating fundamentals, free cash flow this year will show a significant improvement,&#8221; said Bret Yunker, CFO of Caesars. 
CZR Price Action: <a href="http://benzinga.com/quote/czr">Caesars shares</a> were up 2.54% after-hours, trading at $28.70 at the time of publication Tuesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/social-media/25/04/45084721/snap-hits-900-million-users-beats-q1-estimates-but-stock-slides-on-uncertainty">Snap Hits 900 Million Users, Beats Q1 Estimates, But Stock Slides On &#8216;Uncertainty&#8217;</a></li>
</ul>
Photo: Shutterstock.

Entertainment

Gaming

After-Hours Center

Caesars Entertainment Reports Q1 Earnings, Company Targets Accelerated Free Cash Flow In 2025

Barrington Research analyst Patrick Sholl maintains Travelzoo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TZOO#NASDAQ">TZOO</a>) with a Outperform and maintains $17 price target.

TZOO

Barrington Research Maintains Outperform on Travelzoo, Maintains $17 Price Target

KKR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KKR#NYSE">KKR</a>) has outperformed the market over the past 10 years by 7.24% on an annualized basis producing an average annual return of 17.49%. Currently, KKR has a market capitalization of $101.39 billion. 
Buying $1000 In KKR: If an investor had bought $1000 of KKR stock 10 years ago, it would be worth $5,021.96 today based on a price of $114.15 for KKR at the time of writing.
<h3>KKR's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745962239_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $1000 Invested In KKR 10 Years Ago Would Be Worth Today

Seagate Technology Holdings PLC (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STX#NASDAQ">STX</a>) released its third-quarter results after Tuesday's closing bell. Here's a look at the details<a href="https://www.benzinga.com/pressreleases/25/04/b45082722/seagate-technology-reports-fiscal-third-quarter-2025-financial-results"> from the quarter. </a>
The Details: Seagate Technology reported quarterly earnings of $1.90 per share, which missed the analyst consensus estimate of $2.09. Quarterly revenue of $2.16 billion missed the consensus estimate of $2.31 billion and is an increase over sales of $1.66 billion from the same period last year.
Read Next: <a href="https://www.benzinga.com/news/legal/25/04/45056354/alexandria-ocasio-cortez-askshow-much-did-majorie-taylor-greene-make-when-she-bought-the-dip?utm_source=articleShare">Alexandria Ocasio-Cortez Asks,&#8217;How Much Did Majorie Taylor Greene Make When She Bought The Dip?&#8217;</a>
Seagate&#8217;s board of directors declared a quarterly cash dividend of 72 cents per share payable on July 8, 2025, to shareholders of record as of the close of business on June 25, 2025.
&#8220;Seagate delivered another solid quarter of profitable year-on-year growth and margin expansion, elevating our non-GAAP EPS to the top of our guidance range. Our performance underscores the structural enhancements we&#8217;ve made to our business model and healthy supply/demand environment for mass capacity storage,&#8221; said Dave Mosley, Seagate&#8217;s CEO. 
Outlook: Seagate sees fourth-quarter adjusted earnings of between $2.20 and $2.60 per share, versus the $2.20 analyst estimate, and revenue in a range of $2.25 billion to $2.55 billion, versus the $2.43 billion estimate.
STX Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Seagate stock was up 7.87% after hours at $88.02 on Tuesday.  
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/general/social-media/25/04/45076599/sell-in-may-and-go-away-only-in-bear-markets-one-expert-says?utm_source=articleShare">&#8216;Sell In May And Go Away?&#8217; Only In Bear Markets, One Expert Says&nbsp;</a></li>
</ul>
Photo: Shutterstock

Tech

Seagate Technology Shares Climb After Q3 Results, Q4 EPS Guidance Above Estimates

TPG RE Finance Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TRTX#NYSE">TRTX</a>) reported quarterly earnings of $0.24 per share which missed the analyst consensus estimate of $0.25 by 4 percent. This is a 20 percent decrease over earnings of $0.30 per share from the same period last year. The company reported quarterly sales of $37.03 million which beat the analyst consensus estimate of $25.00 million by 48.13 percent. This is a 4.87 percent decrease over sales of $38.93 million the same period last year.

TRTX

TPG RE Finance Trust Q1 Adj. EPS $0.24 Misses $0.25 Estimate, Sales $37.03M Beat $25.00M Estimate

Press Releases

Coya Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Coya Therapeutics Reports Statistically Significant Improvement of Inflammatory Blood Markers in Patients with Alzheimer's Disease Following Monthly Dosing with Low-Dose IL-2, Further Supporting Clinical Development

Coya Therapeutics to Participate in KOL Call Hosted by BTIG to Discuss the Potential Treatment of Alzheimer's Disease Using GLP-1 Agonists and Combinations

Coya Therapeutics Provides a Corporate Update and Reports Fiscal 2024 Financial Results

The Radoff-JEC Group Nominates Three Highly Qualified Candidates for Election to the Atea Pharmaceuticals Board of Directors

Coya Therapeutics Reports Progress from an Academic Supported First-in-Class Treg-derived Exosome Program

Coya Therapeutics Selected for Platform Presentation at the ADPD 2025 Conference in Vienna on April 5, 2025

Atea Pharmaceuticals Appoints Howard H. Berman to Board of Directors and Announces Share Repurchase Program

Coya Therapeutics Announces Publication of GLP-1/LD IL-2 Combination Biologic (COYA 303) Demonstrating Synergistic Enhancement of Regulatory T Cell Function and Protection Against Treg Apoptosis (Cell Death)

Biotech

Coya Therapeutics Announces Positive Interim Results of an Investigator-Initiated Open Label Study with Low-Dose IL-2 and CTLA4-Ig Combination Treatment in Five Patients with Mild to Moderate Frontotemporal Dementia

Comments

Coya Therapeutics

Notizie

Ultime notizie per Coya Therapeutics (NASDAQ:COYA) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO